Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Cash from Investing Activities (2022 - 2023)

Historic Cash from Investing Activities for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$261808.0.

  • Mainz Biomed's Cash from Investing Activities fell 166349.18% to -$261808.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.9 million, marking a year-over-year decrease of 18836.6%. This contributed to the annual value of -$198817.0 for FY2024, which is 8952.96% up from last year.
  • As of Q4 2023, Mainz Biomed's Cash from Investing Activities stood at -$261808.0, which was down 166349.18% from -$112478.0 recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed's Cash from Investing Activities ranged from a high of -$14846.0 in Q4 2022 and a low of -$1.4 million during Q1 2023